Abstract | BACKGROUND AND PURPOSE: Previous studies have shown that atherosclerotic lesions express a number of matrix metalloproteinases ( MMPs). Here we investigated whether transcript levels of MMP-1, -3, -7, -9, and -12 in carotid atherosclerotic plaques were correlated with histological features and clinical manifestations. METHODS: RESULTS: Compared to plaques with a thick fibrous cap, those with a thin cap had a 7.8-fold higher MMP-1 transcript level (P=0.006). MMP-3, -7, and -12 were 1.5-fold, 1.8-fold, and 2.1-fold, respectively, higher in thin cap plaques, but the differences did not reach statistical significance. MMP-12 transcript levels were significantly increased in ruptured plaques compared with lesions without cap disruption (P=0.001). MMP-9 transcript levels were similar among the different types of lesion. MMP-1 and -12 transcript levels were significantly higher in plaques from patients with amaurosis fugax, than in those from asymptomatic patients (P=0.029 and P=0.008 for MMP-1 and MMP-12, respectively), than in those from patients with stroke (P=0.027 and P=0.001, respectively), and than in those from patients with transient ischemic attack (P=0.046 and P=0.008, respectively). CONCLUSIONS:
|
Authors | Angharad R Morgan, Kittipan Rerkasem, Patrick J Gallagher, Baiping Zhang, Gareth E Morris, Philip C Calder, Robert F Grimble, Per Eriksson, William L McPheat, Clifford P Shearman, Shu Ye |
Journal | Stroke
(Stroke)
Vol. 35
Issue 6
Pg. 1310-5
(Jun 2004)
ISSN: 1524-4628 [Electronic] United States |
PMID | 15073384
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- RNA, Messenger
- Metalloendopeptidases
- MMP12 protein, human
- Matrix Metalloproteinase 12
- Matrix Metalloproteinase 1
|
Topics |
- Aged
- Carotid Artery Diseases
(diagnosis, pathology)
- Female
- Humans
- Male
- Matrix Metalloproteinase 1
(biosynthesis, genetics)
- Matrix Metalloproteinase 12
- Metalloendopeptidases
(biosynthesis, genetics)
- RNA, Messenger
(metabolism)
|